Oncology Sponsored 12 Questions with Julia Jakl Learn more about Julia Jakl, VP and Business Unit Head, Oncology UK at GSK, in a new 12 Questions With.
Patients Sponsored 12 Questions with Kim Innes Kim Innes is General Manager of Teva UK. She has more than 30 years’ experience across the pharmaceutical industry.
Sales & Marketing Sponsored 12 Questions with Kevin Asher Kevin Asher leads Acumetis's Medical Practice, bringing 15+ years in Medical Affairs to teams across the industry.
Digital Sponsored 12 Questions with Sam Dixey Find out more about Sam Dixey, Head of Medical Affairs Innovation and Technology (MAIT) at LUCENT Biopharma.
Sales & Marketing Sponsored 12 Questions with Shauna Lord Shauna Lord recently joined GSK as Business Unit Head Specialty (UK Commercial) to lead the Specialty business in the UK.
R&D Sponsored 12 Questions With Marie Teil Marie Teil is a pharmaceutical executive with over 20 years of experience in the healthcare field. She leads UCB's Women of Childbearing Age programme
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.